TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
TYK Medicines, Inc. Class H ( (HK:2410) ) has shared an update.
TYK Medicines, Inc, a company incorporated in the People’s Republic of China, announced the resignation of Mr. Zhang Senquan as an independent non-executive director, effective September 15, 2025. This resignation has led to temporary non-compliance with several Hong Kong Stock Exchange listing rules, as Mr. Zhang was a key member of various committees. The company is actively seeking a suitable candidate to fill the vacancy and ensure compliance within three months.
The most recent analyst rating on (HK:2410) stock is a Buy with a HK$31.60 price target. To see the full list of analyst forecasts on TYK Medicines, Inc. Class H stock, see the HK:2410 Stock Forecast page.
More about TYK Medicines, Inc. Class H
Average Trading Volume: 6,367,688
Technical Sentiment Signal: Strong Sell
Current Market Cap: HK$5.5B
Learn more about 2410 stock on TipRanks’ Stock Analysis page.